# Ranolazine

NDC: 63304-017
Generic name: Ranolazine
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20190528

FDA application: ANDA211707

## Active ingredients

- RANOLAZINE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63304-017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63304-017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5848232-b7fd-4fe5-a543-16d6c4b5c0b1